slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.435
KRW
|
-0,20%
|
|
-4,70%
|
-12,25%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
698.724
|
612.557
|
821.286
|
450.793
|
241.175
|
208.277
|
Bedrijfswaarde
1 |
578.661
|
556.353
|
744.096
|
403.016
|
229.340
|
195.990
|
K/w-verhouding
|
93,5
x
|
-15,9
x
|
-78,7
x
|
-28,5
x
|
-10,1
x
|
-4,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
50,3
x
|
43,7
x
|
27,2
x
|
10,6
x
|
6,24
x
|
42,7
x
|
Bedrijfswaarde/omzet
|
41,7
x
|
39,7
x
|
24,6
x
|
9,51
x
|
5,93
x
|
40,2
x
|
Bedrijfswaarde/EBITDA
|
192
x
|
-63,8
x
|
-141
x
|
-105
x
|
-10,9
x
|
-6,78
x
|
Bedrijfswaarde/FCF
|
-112
x
|
-14,5
x
|
36,6
x
|
-21,6
x
|
-7,76
x
|
24,7
x
|
FCF Yield
|
-0,9%
|
-6,91%
|
2,73%
|
-4,63%
|
-12,9%
|
4,05%
|
Price to Book
|
3,8
x
|
4,12
x
|
3,85
x
|
2,15
x
|
1,28
x
|
1,46
x
|
Aantal aandelen (in duizenden)
|
60.583
|
62.083
|
68.823
|
68.096
|
68.907
|
75.055
|
Referentieprijs
2 |
11.533
|
9.867
|
11.933
|
6.620
|
3.500
|
2.775
|
Datum van publicatie
|
14/03/19
|
19/03/20
|
23/03/21
|
18/03/22
|
21/03/23
|
15/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
13.887
|
14.007
|
30.223
|
42.376
|
38.642
|
4.879
|
EBITDA
1 |
3.016
|
-8.714
|
-5.294
|
-3.851
|
-20.956
|
-28.920
|
Bedrijfsresultaat (EBIT)
1 |
1.756
|
-10.560
|
-10.210
|
-6.846
|
-23.969
|
-32.119
|
Operationele Marge
|
12,65%
|
-75,39%
|
-33,78%
|
-16,16%
|
-62,03%
|
-658,37%
|
Resultaat voor belastingen (EBT)
1 |
7.148
|
-37.725
|
-14.011
|
-15.617
|
-25.035
|
-51.152
|
Nettowinst (verlies)
1 |
6.908
|
-37.585
|
-9.838
|
-15.901
|
-23.869
|
-48.924
|
Nettomarge
|
49,74%
|
-268,34%
|
-32,55%
|
-37,52%
|
-61,77%
|
-1.002,81%
|
WPA
2 |
123,3
|
-618,8
|
-151,6
|
-232,2
|
-345,0
|
-661,3
|
Free Cash Flow
1 |
-5.186
|
-38.459
|
20.341
|
-18.668
|
-29.538
|
7.942
|
FCF-marge
|
-37,34%
|
-274,58%
|
67,3%
|
-44,05%
|
-76,44%
|
162,78%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14/03/19
|
19/03/20
|
23/03/21
|
18/03/22
|
21/03/23
|
15/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
120.062
|
56.204
|
77.191
|
47.777
|
11.835
|
12.287
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5.186
|
-38.459
|
20.341
|
-18.668
|
-29.538
|
7.942
|
ROE (netto-inkomsten/eigen vermogen)
|
5%
|
-18,6%
|
-6,76%
|
-8,43%
|
-11,9%
|
-26,7%
|
ROA (netto-inkomsten/totale activa)
|
0,58%
|
-2,08%
|
-1,83%
|
-1,32%
|
-4,57%
|
-7,1%
|
Totale activa
1 |
1.184.226
|
1.811.257
|
536.627
|
1.207.620
|
522.262
|
689.366
|
Nettoactief per aandeel
2 |
3.033
|
2.395
|
3.102
|
3.072
|
2.732
|
1.898
|
Cashflow per aandeel
2 |
575,0
|
836,0
|
682,0
|
458,0
|
435,0
|
301,0
|
Capex
1 |
293
|
618
|
6.748
|
10.607
|
14.632
|
23.236
|
Capex/omzet
|
2,11%
|
4,41%
|
22,33%
|
25,03%
|
37,87%
|
476,27%
|
Datum van publicatie
|
14/03/19
|
19/03/20
|
23/03/21
|
18/03/22
|
21/03/23
|
15/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -12,25% | 135 mln. | | +40,73% | 739 mld. | | +32,83% | 598 mld. | | -6,30% | 353 mld. | | +15,15% | 318 mld. | | +4,05% | 285 mld. | | +15,00% | 240 mld. | | -5,52% | 206 mld. | | +6,17% | 164 mld. | | -0,45% | 162 mld. |
Farmaceutische producten - Andere
|